Skip to main content
. 2014 Dec 5;25(5):575–586. doi: 10.1111/bpa.12217

Table 3.

BRAF V600E mutation status

BRAF V600E mutation First diagnosis
PXA (n = 51) PXA‐AF (n = 23)
Final status
Mutant 30 (73.2%) 9 (47.4%)
Nonmutant 10 (24.4%) 10 (52.6%)
Indeterminate 1 (2.4%) 0
NA 10 4
By immunohistochemistry
Positive 30 (73.2%) 9 (47.4%)
Negative 10 (24.4%) 6 (31.6%)
Indeterminate 1 (2.4%) 4 (21.1%)
NA 10 4
By molecular genetics
Mutant 18 (69.2%) 6 (46.2%)
Nonmutant 8 (30.8%) 7 (53.8%)
NA 25 10